Fox News: Genmab Initiates Zalutumumab Combination Study in Colorectal Cancer

[riky]

Genmab Initiates Zalutumumab Combination Study in Colorectal Cancer
     

Summary: Genmab has Initiated a Phase I/II Study of Zalutumumab in Combination With Irinotecan Chemotherapy to Treat Refractory Colorectal Cancer Patients<img src="You are not allowed to view links. Register or Login" height="1" width="1"/><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
     

You are not allowed to view links. Register or Login